Levaquin and Roxanol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Levaquin (levofloxacin) and Roxanol (morphine sulfate). Common drug interactions include oedema peripheral among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Levaquin and Roxanol. It is created by eHealthMe based on reports of 93 people who take the same drugs from the FDA, and is updated regularly.

What is Levaquin?

Levaquin has active ingredients of levofloxacin. It is often used in sinusitis. eHealthMe is studying from 56,638 Levaquin users. Check the latest studies of Levaquin.

What is Roxanol?

Roxanol has active ingredients of morphine sulfate. eHealthMe is studying from 807 Roxanol users. Check the latest studies of Roxanol.



On Aug, 06, 2026

93 people who take Levaquin and Roxanol together, and have interactions are studied.

Levaquin and Roxanol drug interactions.

What are the common drug interactions of Levaquin and Roxanol, by gender? *:

female:

  1. Oedema peripheral (superficial swelling)
  2. Nausea (feeling of having an urge to vomit)
  3. Asthenia (weakness)
  4. Osteonecrosis of jaw (death of bone of jaw)
  5. Back pain
  6. Cough
  7. Metastases to bone (cancer spreads to bone)
  8. Bone disorder
  9. Pain in extremity
  10. Deformity (disfigurement)

male:

  1. Anxiety
  2. Pain
  3. Diarrhoea
  4. Fatigue (feeling of tiredness)
  5. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  6. Back pain
  7. Cardiomegaly (increased size of heart than normal)
  8. Cardiac failure congestive
  9. Metastases to bone (cancer spreads to bone)
  10. Metastases to spine (cancer spreads to spine)

What are the common drug interactions of Levaquin and Roxanol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Seizure (abnormal excessive or synchronous neuronal activity in the brain)

20-29:

n/a

30-39:

  1. Anxiety
  2. Nausea (feeling of having an urge to vomit)
  3. Neuropathy peripheral (surface nerve damage)
  4. Osteonecrosis of jaw (death of bone of jaw)
  5. Pain
  6. Abdominal pain upper
  7. Asthenia (weakness)
  8. Back pain
  9. Bone disorder
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

40-49:

  1. Anxiety
  2. Injury
  3. Pain
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Depression
  6. Diarrhoea
  7. Fatigue (feeling of tiredness)
  8. Metastases to bone (cancer spreads to bone)
  9. Metastases to spine (cancer spreads to spine)
  10. Myalgia (muscle pain)

50-59:

  1. Cough
  2. Rash
  3. Dysuria (painful or difficult urination)
  4. Emotional distress
  5. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  6. Joint stiffness
  7. Mobility decreased (ability to move is reduced)
  8. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  9. Skin exfoliation (removal of the oldest dead skin cells)
  10. Skin fibrosis (fibrous tissue formation on skin)

60+:

  1. Anxiety
  2. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  3. Nausea (feeling of having an urge to vomit)
  4. Neuropathy peripheral (surface nerve damage)
  5. Pleural effusion (water on the lungs)
  6. Pyrexia (fever)
  7. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  8. Bone disorder
  9. Cardiomegaly (increased size of heart than normal)
  10. Cellulitis (infection under the skin)

What are the existing conditions these people have? *

  1. Pain: 33 people, 35.48%
  2. Nausea (feeling of having an urge to vomit): 16 people, 17.20%
  3. Multiple Myeloma (cancer of the plasma cells): 16 people, 17.20%
  4. Nuclear Magnetic Resonance Imaging Brain: 11 people, 11.83%
  5. Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 11 people, 11.83%
  6. High Blood Cholesterol: 11 people, 11.83%
  7. Depression: 11 people, 11.83%
  8. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 11 people, 11.83%
  9. Bone Density Decreased: 11 people, 11.83%
  10. Stress And Anxiety: 10 people, 10.75%

* Approximation only. Some reports may have incomplete information.

Do you take Levaquin and Roxanol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Levaquin and Roxanol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Levaquin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Roxanol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levaquin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Roxanol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on levofloxacin and morphine sulfate (the active ingredients of Levaquin and Roxanol, respectively), and Levaquin and Roxanol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: